[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:connective-tissue-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":49,"states":50},"Connective Tissue Disorder",6,5,[8,16,23,30,36,42],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06576271","A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants",[12],"Phase 1","RECRUITING","2026-08-26T02:18:13.438956Z","2026-07-05T05:32:16.765412Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06716606","A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)",[20],"Phase 3","2026-08-26T02:16:38.897933Z","2026-05-05T02:43:29.473028Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT06104228","129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)",[27],"Phase 2","2026-08-26T02:17:01.714035Z","2026-05-05T02:43:27.672925Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT00470327","A Study of the Natural Progression of Interstitial Lung Disease (ILD)",[],"2026-08-26T02:16:22.235886Z","2026-05-13T02:55:06.035938Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07477197","Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders",[],"2026-08-26T02:15:29.632183Z","2026-05-13T02:55:06.708614Z",{"nct_id":43,"title":44,"phases":45,"status":46,"updated_at":47,"content_modified":48},"NCT04896138","University of Virginia Natural History Study",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:51.982021Z","2026-07-05T18:42:10.714751Z",[],[]]